Díaz Pérez D, Laso García I, Sánchez Guerrero C, Fernández Alcalde Á, Ruiz Hernández M, Brasero Burgos J, Lorca Álvaro J, Duque Ruiz G, Arias Funez F, Burgos Revilla F J
Servicio de Urología, Hospital Universitario Ramón y Cajal, Instituto de Investigación Sanitaria IRYCIS, Madrid, España.
Servicio de Urología, Hospital Universitario Ramón y Cajal, Instituto de Investigación Sanitaria IRYCIS, Madrid, España.
Actas Urol Esp (Engl Ed). 2019 Jul-Aug;43(6):293-299. doi: 10.1016/j.acuro.2019.02.001. Epub 2019 May 2.
To evaluate the incidence, clinical presentation and factors associated with the development of urinary sepsis after performing ureterorenoscopy.
Retrospective study of patients undergoing ureterorenoscopy for the treatment of lithiasis between July 2015 and October 2017. Patients who developed urinary sepsis during the 30 days following the intervention were identified. Personal, clinical, surgical and microbiological backgrounds were collected. Statistical analysis was performed with the Chi squared test (or Fisher's exact test), Student's t (or U Mann-Whitney) or logistic regression as appropriate.
246 ureterorenoscopies were performed, 184 (74.8%) on ureteral stones and 62 (25.2%) on kidney stones, with a mean age of 52 (44.5-59.5) years. After procedure, 18 (7.3%) patients developed urinary sepsis, 10 of them (55.5%) occurred in the first 24h. The urine culture showed enterobacteria (61.1%) and enterococci (38.9%). The antibiogram showed greater sensitivity to nitrofurantoins (100%) and quinolones (72%). The statistical analysis showed that female sex, the clinical debut of urolithiasis as urinary sepsis, having received antibiotic or having required urinary diversion by a double J during debut, positive presurgical uroculture and the persistence of residual lithiasis after surgery were significantly associated (P<.05) with the development of urinary sepsis after ureterorenoscopy.
Urinary sepsis is a complication that appears after performing ureterorenoscopy, especially in female patients with a history of urinary sepsis, antibiotic therapy, double J, previous positive urine culture or residual lithiasis after the procedure.
评估输尿管肾镜检查术后尿脓毒症的发生率、临床表现及相关因素。
回顾性研究2015年7月至2017年10月期间因治疗结石而行输尿管肾镜检查的患者。确定干预后30天内发生尿脓毒症的患者。收集患者的个人、临床、手术及微生物学背景资料。根据情况采用卡方检验(或Fisher精确检验)、Student t检验(或U Mann-Whitney检验)或逻辑回归进行统计分析。
共进行了246例输尿管肾镜检查,其中184例(74.8%)针对输尿管结石,62例(25.2%)针对肾结石,平均年龄为52岁(44.5 - 59.5岁)。术后,18例(7.3%)患者发生尿脓毒症,其中10例(55.5%)发生在术后24小时内。尿培养显示肠杆菌(61.1%)和肠球菌(38.9%)。药敏试验显示对呋喃妥因(100%)和喹诺酮类(72%)敏感性更高。统计分析表明,女性、以尿脓毒症为首发表现的尿路结石、首发时接受过抗生素治疗或需要通过双J管进行尿液改道、术前尿培养阳性以及术后残留结石与输尿管肾镜检查术后尿脓毒症的发生显著相关(P<0.05)。
尿脓毒症是输尿管肾镜检查术后出现的一种并发症,尤其在有尿脓毒症病史、接受过抗生素治疗、使用过双J管、术前尿培养阳性或术后有残留结石史的女性患者中。